Your browser is no longer supported. Please, upgrade your browser.
Settings
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E34.81 EPS (ttm)8.81 Insider Own0.20% Shs Outstand401.00M Perf Week4.13%
Market Cap123.03B Forward P/E22.56 EPS next Y13.60 Insider Trans-11.54% Shs Float400.36M Perf Month8.96%
Income3.56B PEG3.06 EPS next Q3.54 Inst Own92.20% Short Float0.82% Perf Quarter9.76%
Sales25.22B P/S4.88 EPS this Y23.10% Inst Trans0.58% Short Ratio2.34 Perf Half Y16.70%
Book/sh73.20 P/B4.19 EPS next Y10.36% ROA6.30% Target Price314.80 Perf Year30.51%
Cash/sh3.19 P/C96.12 EPS next 5Y11.37% ROE12.70% 52W Range208.34 - 306.95 Perf YTD37.10%
Dividend0.76 P/FCF33.70 EPS past 5Y16.60% ROI7.70% 52W High-1.94% Beta1.12
Dividend %0.25% Quick Ratio1.20 Sales past 5Y13.20% Gross Margin44.50% 52W Low44.47% ATR5.53
Employees70000 Current Ratio1.80 Sales Q/Q5.90% Oper. Margin17.90% RSI (14)54.97 Volatility1.69% 1.77%
OptionableYes Debt/Eq0.58 EPS Q/Q-0.60% Profit Margin14.20% Rel Volume0.77 Prev Close306.81
ShortableYes LT Debt/Eq0.56 EarningsOct 23 BMO Payout8.00% Avg Volume1.41M Price300.99
Recom1.70 SMA201.51% SMA503.40% SMA2008.33% Volume1,090,547 Change-1.90%
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
May-30-19Initiated Wolfe Research Outperform
May-23-19Reiterated Needham Strong Buy $313 → $315
Apr-22-19Reiterated Needham Strong Buy $271 → $312
Apr-16-19Reiterated BofA/Merrill Buy $285 → $300
Jan-03-19Initiated Needham Strong Buy $271
Oct-18-18Downgrade Cleveland Research Buy → Neutral
Oct-09-18Initiated UBS Buy
Sep-24-18Reiterated Barclays Overweight $250 → $275
Sep-17-18Downgrade Goldman Buy → Neutral
Feb-01-18Reiterated Barclays Overweight $225 → $245
Jan-05-18Initiated BTIG Research Buy
Sep-06-17Resumed Morgan Stanley Overweight $220
Jul-20-17Upgrade Cleveland Research Neutral → Buy
May-19-17Initiated Cantor Fitzgerald Overweight $194
May-09-17Reiterated Barclays Overweight $175 → $190
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Nov-18-19 09:56AM  Canopy Growth (CGC) Q2 Earnings & Revenues Miss Estimates Zacks
06:52AM  Dutch Diagnostics Group Qiagen Is Looking Like a Hot Acquisition And Shares Are Soaring Barrons.com
Nov-15-19 05:12PM  Medtech Stock With 28% Gain This Week Confirms It's Fielding Buyout Bids Investor's Business Daily
03:58PM  UPDATE 1-Qiagen exploring sale after indications of interest Reuters
12:29PM  Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios Benzinga
Nov-14-19 04:23PM  This Medtech Stock Jumped Bullishly On A Rumored $8 Billion Takeover Investor's Business Daily
10:46AM  The Zacks Analyst Blog Highlights: AMETEK, Thermo Fisher Scientific, IQVIA, Lowe's Companies and Alexion Pharmaceuticals Zacks
09:15AM  Qiagen's stock extends surge after J.P. Morgan swings to bullish from bearish MarketWatch
07:14AM  Thermo Fisher Considers Buying $8 Billion Diagnostics Firm Qiagen Bloomberg
05:34AM  Worries Over China Pressure European Stocks As German Economy Stagnates Barrons.com
05:22AM  European stocks edge lower on China trade concerns and worst of all worlds German economic data MarketWatch
04:35AM  [video]Qiagen Jumps on Report Thermo Fisher Is Considering a Bid TheStreet.com
Nov-13-19 05:32PM  Thermo Fisher approaches genetic testing specialist Qiagen for deal - Bbg Reuters
07:54AM  5 Most-Loved S&P 500 Stocks on Wall Street Zacks
Nov-11-19 07:34AM  Penumbra's (PEN) Q3 Earnings & Revenues Surpass Estimates Zacks
Nov-08-19 09:25AM  Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out? Zacks
09:15AM  Nevro (NVRO) Q3 Loss Narrower Than Expected, Revenues Up Y/Y Zacks
09:11AM  DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3 Zacks
09:08AM  Glaukos (GKOS) Q3 Loss Narrower Than Expected, '19 View Up Zacks
09:06AM  LHC Group (LHCG) Q3 Earnings Surpass Estimates, Revenues Lag Zacks
08:21AM  Thermo Fisher sets new $2.5 billion stock buyback program MarketWatch
08:11AM  National Vision's (EYE) Q3 Earnings Top Estimates, View Raised Zacks
08:00AM  Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases PR Newswire
Nov-07-19 11:18AM  Option Care Health (BIOS) Q3 Earnings Meet, Revenues Top Zacks
10:28AM  DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Ups '19 View Zacks
10:23AM  Globus Medical (GMED) Q3 Earnings Meet Mark, Revenue View Up Zacks
10:10AM  Hologic's (HOLX) Q4 Earnings Meet, Revenues Top Estimates Zacks
09:41AM  Cardinal Health (CAH) Q1 Earnings & Revenues Beat Estimates Zacks
09:40AM  AmerisourceBergen (ABC) Q4 Earnings & Revenues Beat Estimates Zacks
08:53AM  Insulet (PODD) Beats on Q3 Earnings, Ups '19 Revenue View Zacks
08:16AM  OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat Zacks
Nov-06-19 10:57AM  CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance Zacks
10:43AM  Phibro's (PAHC) Q1 Earnings & Revenues Fall Y/Y, Margins Down Zacks
10:05AM  HMS Holdings (HMSY) Q3 Earnings Top Estimates, Revenues Miss Zacks
09:59AM  Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3 Zacks
09:46AM  Zacks.com featured highlights include: SYNNEX, Thermo Fisher Scientific, Allstate, Intel and Target Zacks
09:13AM  Inogen's (INGN) Q3 Earnings and Revenues Beat Estimates Zacks
09:09AM  DaVita (DVA) Earnings and Revenues Beat Estimates in Q3 Zacks
07:49AM  STERIS' (STE) Q2 Earnings Surpass Estimates, FY20 View Up Zacks
Nov-05-19 11:34AM  Zimmer Biomet (ZBH) Q3 Earnings Top, Operating Margin Falls Zacks
11:29AM  Hill-Rom's (HRC) Q4 Earnings Beat on Strong Global Sales Zacks
10:50AM  Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y Zacks
10:41AM  Luminex (LMNX) Reports Q3 Loss, Misses Revenue Estimates Zacks
10:40AM  Myriad Genetics (MYGN) Lags Q1 Earnings and Revenue Estimates Zacks
10:38AM  Henry Schein (HSIC) Q3 Earnings Top Estimates, Revenues Lag Zacks
10:36AM  Becton, Dickinson (BDX) Beats on Q4 Earnings and Revenues Zacks
09:18AM  Tandem Diabetes (TNDM) Q3 Loss Narrows Y/Y, Sales Improve Zacks
09:16AM  5 Excellent Dividend Growth Stocks on Sale Zacks
Nov-04-19 09:53AM  Intersect ENT (XENT) Reports Q3 Loss, Revenues Meet Estimates Zacks
09:49AM  Haemonetics (HAE) Beats on Q2 Earnings, Raises '20 EPS View Zacks
07:35AM  Surmodics (SRDX) Q4 Earnings and Revenues Beat Estimates Zacks
Nov-01-19 12:03PM  Bio-Rad (Bio) Q3 Earnings Beat Estimates on All-Line Growth Zacks
10:26AM  Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View Zacks
10:22AM  Integer Holdings (ITGR) Beats on Q3 Earnings, Revenues Miss Zacks
09:50AM  Bruker (BRKR) Beats Q3 Earnings Estimates, Ups EPS Guidance Zacks
07:58AM  PRA Health (PRAH) Q3 Earnings and Revenues Beat Estimates Zacks
07:57AM  AMN Healthcare (AMN) Q3 Earnings and Revenues Top Estimates Zacks
07:19AM  Teleflex (TFX) Earnings and Revenues Beat Estimates in Q3 Zacks
06:35AM  NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q3 Zacks
Oct-31-19 02:25PM  Impressive Near-Term Outlook for Medical Instruments Industry Zacks
12:17PM  Amedisys (AMED) Q3 Earnings Beat Estimates, Revenues Meet Zacks
10:44AM  IDEXX (IDXX) Tops Q3 Earnings Estimates, Lowers EPS View Zacks
10:09AM  CONMED (CNMD) Q3 Earnings and Revenues Surpass Estimates Zacks
10:01AM  Merit Medical (MMSI) Q3 Earnings & Revenues Miss Estimates Zacks
09:34AM  PerkinElmer (PKI) Q3 Earnings Beat Estimates, Revenues Miss Zacks
09:01AM  ABIOMED (ABMD) Earnings Beat, Revenues Miss Estimates in Q2 Zacks
08:09AM  QIAGEN (QGEN) Beats Q3 Earnings Estimates, Cuts Revenue View Zacks
07:35AM  Masimo (MASI) Earnings Beat Estimates in Q3, View Raised Zacks
Oct-30-19 03:38PM  How Did Thermo Fisher Scientific Inc.'s (NYSE:TMO) 12% ROE Fare Against The Industry? Simply Wall St.
10:33AM  Chemed (CHE) Q3 Earnings Surpass Estimates, Revenues Miss Zacks
10:18AM  McKesson (MCK) Q2 Earnings Meet Estimates, Revenues Beat Zacks
10:15AM  Fresenius Medical (FMS) Q3 Earnings & Revenues Top Estimates Zacks
10:13AM  Stryker (SYK) Q3 Earnings Meet Estimates, Revenues Beat Zacks
08:27AM  Cardiovascular Systems (CSII) Loss Wider Than Estimates in Q1 Zacks
08:27AM  Accuray (ARAY) Q1 Wider Than Expected, FY20 View Retained Zacks
Oct-29-19 11:26AM  Ecolab (ECL) Earnings and Revenues Miss Estimates in Q3 Zacks
09:30AM  Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year? Zacks
Oct-28-19 09:33AM  Walgreens Boots (WBA) Q4 Earnings Surpass, Margins Fall Zacks
Oct-25-19 11:42AM  Omnicell (OMCL) Beats on Q3 Earnings, Raises '19 EPS View Zacks
10:51AM  Cerner (CERN) Earnings Beat Estimates in Q3, Improve Y/Y Zacks
10:27AM  NextGen (NXGN) Q2 Earnings Beat, Revenues Miss Estimates Zacks
10:11AM  GNC Holdings (GNC) Q3 Loss Meets Estimates, Revenues Miss Zacks
09:30AM  TMO vs. EW: Which Stock Is the Better Value Option? Zacks
09:18AM  Illumina (ILMN) Beats Q3 Earnings Estimates, Raises View Zacks
Oct-24-19 01:18PM  Edited Transcript of TMO earnings conference call or presentation 23-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
09:31AM  Company News For Oct 24, 2019 Zacks
Oct-23-19 04:41PM  US STOCKS-Wall Street ticks higher, but chip stocks tumble Reuters +5.67%
04:04PM  These Medtech Giants Are Nearing Breakouts After Earnings 'Crushed' It Investor's Business Daily
03:59PM  US Stocks Advance Wednesday GuruFocus.com
09:38AM  Thermo Fisher (TMO) Beats on Q3 Earnings, Lifts Guidance Zacks
08:06AM  Thermo Fisher Soars After Lab Equipment Maker Posts Earnings Beat TheStreet.com
08:05AM  U.S. Stock Futures Drop After Warnings From Caterpillar and Texas Instruments Barrons.com
07:30AM  Thermo Fisher Scientific (TMO) Q3 Earnings and Revenues Top Estimates Zacks
06:00AM  Thermo Fisher Scientific Reports Third Quarter 2019 Results PR Newswire
02:03AM  Thermo Fisher Scientific Earnings, Revenue Beat in Q3 Investing.com
Oct-22-19 11:25AM  Medical Products' Earnings Roster for Oct 23: TMO, BSX & More Zacks
Oct-18-19 11:02AM  What's in Store for Thermo Fisher (TMO) in Q3 Earnings? Zacks
Oct-16-19 10:32AM  Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-11-19 09:30AM  Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year? Zacks
Oct-10-19 05:56PM  Thermo Fisher Gets a Boost from Buyouts and Global Expansion Zacks
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis equipment; laboratory plastics and chemicals; and pharma services. It has a strategic collaboration with NX Prenatal Inc., Evosep, and Cedars-Sinai; research collaboration with Predictive Laboratories; strategic manufacturing collaboration with Amicus Therapeutics, Inc.; and collaboration with Owlstone Medical. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChief Executive OfficerOct 25Option Exercise73.2447,7293,495,672328,960Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerOct 25Sale295.8847,72914,121,958281,231Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerSep 13Option Exercise73.242,271166,328283,502Sep 17 04:54 PM
CASPER MARC NChief Executive OfficerSep 13Sale298.002,271676,758281,231Sep 17 04:54 PM
MANZI JIM PDirectorAug 15Sale272.931,833500,27927,892Aug 19 04:17 PM
CASPER MARC NChief Executive OfficerJul 30Option Exercise73.2450,0003,662,000342,193Jul 31 04:15 PM
CASPER MARC NChief Executive OfficerJul 30Sale284.8350,00014,241,366292,193Jul 31 04:15 PM
HARRIS C MARTINDirectorJun 05Sale270.7327574,4516,358Jun 06 04:04 PM
Williamson StephenSr. VP and CFOJun 03Sale268.292,500670,72540,029Jun 04 04:06 PM
CASPER MARC NChief Executive OfficerApr 30Option Exercise73.2440,7132,981,820332,906May 01 04:33 PM
CASPER MARC NChief Executive OfficerApr 30Sale273.2140,71311,123,061292,193May 01 04:33 PM
CASPER MARC NChief Executive OfficerApr 29Option Exercise73.2410,000732,400302,193May 01 04:33 PM
CASPER MARC NChief Executive OfficerApr 29Sale273.2510,0002,732,477292,193May 01 04:33 PM
Williamson StephenSr. VP and CFOMar 04Sale266.002,500665,00042,529Mar 05 04:31 PM
Herrema Gregory J.Senior Vice PresidentMar 01Sale263.053,299867,81529,459Mar 05 04:23 PM
Herrema Gregory J.Senior Vice PresidentFeb 25Option Exercise124.2818,3502,280,53834,988Feb 27 04:04 PM
Herrema Gregory J.Senior Vice PresidentFeb 25Sale253.2919,8085,017,12824,988Feb 27 04:04 PM
Herrema Gregory J.Senior Vice PresidentFeb 19Option Exercise73.245,400395,49631,846Feb 20 04:14 PM
Herrema Gregory J.Senior Vice PresidentFeb 19Sale251.515,4001,358,15426,446Feb 20 04:14 PM
HORNSTRA PETER EVP & Chief Accounting OfficerFeb 15Option Exercise129.795,063657,13019,832Feb 20 04:10 PM
HORNSTRA PETER EVP & Chief Accounting OfficerFeb 15Sale250.005,9201,480,00017,057Feb 20 04:10 PM
Williamson StephenSr. VP and CFODec 07Option Exercise73.249,500695,78044,124Dec 11 04:01 PM
Williamson StephenSr. VP and CFODec 07Sale241.459,5002,293,77534,624Dec 11 04:01 PM
Jacks TylerDirectorDec 04Sale251.981,100277,1765,879Dec 04 05:33 PM
Herrema Gregory J.Senior Vice PresidentNov 29Option Exercise73.2410,000732,40036,446Nov 30 04:31 PM
Herrema Gregory J.Senior Vice PresidentNov 29Sale247.0017,2354,257,04526,446Nov 30 04:31 PM
Jacks TylerDirectorNov 19Sale239.754,7721,144,0876,979Nov 20 04:14 PM